Endo International (ENDP) Debt Trading 5.1% Higher

An issue of Endo International PLC (NASDAQ:ENDP) (TSE:ENL) debt rose 5.1% as a percentage of its face value during trading on Friday. The debt issue has a 5.75% coupon and is set to mature on January 15, 2022. The debt is now trading at $96.06 and was trading at $90.50 one week ago. Price moves in a company’s debt in credit markets often anticipate parallel moves in its share price.

Several analysts have recently weighed in on ENDP shares. Mizuho dropped their price target on shares of Endo International to $15.00 and set a “neutral” rating for the company in a research note on Monday, November 26th. TheStreet cut shares of Endo International from a “c-” rating to a “d+” rating in a research note on Tuesday, November 27th. BidaskClub cut shares of Endo International from a “strong-buy” rating to a “buy” rating in a research note on Tuesday, December 18th. ValuEngine raised shares of Endo International from a “strong sell” rating to a “sell” rating in a research note on Monday, January 7th. Finally, Zacks Investment Research upgraded shares of Endo International from a “hold” rating to a “strong-buy” rating and set a $11.00 price objective on the stock in a report on Wednesday, January 9th. Fourteen analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. The company has an average rating of “Hold” and a consensus price target of $16.00.

Shares of ENDP stock traded up $0.04 during trading hours on Friday, hitting $8.44. The company had a trading volume of 4,018,249 shares, compared to its average volume of 3,441,098. Endo International PLC has a fifty-two week low of $5.27 and a fifty-two week high of $18.50. The firm has a market cap of $1.88 billion, a P/E ratio of 2.92 and a beta of 1.21.

Endo International (NASDAQ:ENDP) (TSE:ENL) last issued its quarterly earnings data on Thursday, February 28th. The company reported $0.75 EPS for the quarter, topping the consensus estimate of $0.59 by $0.16. Endo International had a negative net margin of 35.00% and a negative return on equity of 337.13%. During the same period last year, the company posted $0.77 EPS. Analysts forecast that Endo International PLC will post 2.16 EPS for the current fiscal year.

Several hedge funds have recently modified their holdings of ENDP. Norges Bank acquired a new stake in Endo International during the 4th quarter worth approximately $21,218,000. Panagora Asset Management Inc. lifted its holdings in Endo International by 10,718.5% during the 3rd quarter. Panagora Asset Management Inc. now owns 1,775,205 shares of the company’s stock worth $29,877,000 after buying an additional 1,758,796 shares in the last quarter. Teachers Advisors LLC lifted its holdings in Endo International by 230.1% during the 3rd quarter. Teachers Advisors LLC now owns 1,468,025 shares of the company’s stock worth $24,707,000 after buying an additional 1,023,350 shares in the last quarter. Canada Pension Plan Investment Board lifted its holdings in Endo International by 143,723.6% during the 4th quarter. Canada Pension Plan Investment Board now owns 730,624 shares of the company’s stock worth $5,333,000 after buying an additional 730,116 shares in the last quarter. Finally, Oregon Public Employees Retirement Fund acquired a new stake in Endo International during the 4th quarter worth approximately $76,000. Hedge funds and other institutional investors own 98.25% of the company’s stock.

COPYRIGHT VIOLATION NOTICE: “Endo International (ENDP) Debt Trading 5.1% Higher” was reported by Community Financial News and is the sole property of of Community Financial News. If you are accessing this piece of content on another website, it was copied illegally and reposted in violation of U.S. & international copyright and trademark legislation. The original version of this piece of content can be accessed at https://www.com-unik.info/2019/03/15/endo-international-endp-debt-trading-5-1-higher.html.

Endo International Company Profile (NASDAQ:ENDP)

Endo International plc, a specialty pharmaceutical company, manufactures and sells generic and branded pharmaceuticals in the United States, Canada, and internationally. The company operates through three segments: U.S. Generic Pharmaceuticals, U.S. Branded Pharmaceuticals, and International Pharmaceuticals.

Read More: Investing in Dividend Stocks

Receive News & Ratings for Endo International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Endo International and related companies with MarketBeat.com's FREE daily email newsletter.



Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit